Compare Cardinal Health Inc (CAH) vs Tapestry, Inc. (TPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Tapestry, Inc. — how do they compare? Cardinal Health Inc trades at $236.58 (market cap $55.88B), while Tapestry, Inc. trades at $153.33 (market cap $32.44B). The key difference: Cardinal Health Inc is the larger of the two by market cap, and Tapestry, Inc. pays the higher dividend (1%). Which is the better fit depends on your goals.
| CAH | TPR | |
|---|---|---|
Market Cap | $55.88B | $32.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $240.26 | $164.78 |
52-Week Low | $146.04 | $95.69 |
Enterprise Value | $59.91B | $35.29B |
Dividend Yield | 0.86% | 1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $237.18, up 0.33% on the day, near its 52-week high. The stock shows bullish technical signals with consistent earnings beats, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue reached $222.58 billion in 2025, with net income margin improving to 0.67%. Positive sentiment is driven by strong Q4 2026 results and optimistic fiscal 2027 guidance highlighted by Reuters on August 11, 2026.
Outlook remains favorable with analyst consensus price target of $266.43 implying 12% upside. Key opportunities include pharmaceutical segment strength and dividend payments, while risks involve high debt levels and thin profit margins. The bullish analyst stance (54.55% buy ratings) supports growth potential, but investors should monitor cash flow volatility and competitive pressures.
TPR trades at $164.78, up 1.49% with strong technical momentum and bullish moving averages. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $1.66 exceeding the $1.30 estimate. Analyst sentiment remains overwhelmingly positive with 31 buy ratings and a $190.33 consensus price target, representing 15.5% upside potential. Recent news highlights Tapestry's AI initiatives and strong brand momentum driving market share gains.
The outlook appears favorable given TPR's earnings beat streak and positive analyst coverage, though elevated valuation ratios (P/E 48.95, P/S 4.34) and recent net income margin compression from 12.23% to 2.61% warrant monitoring. Key risks include competitive pressures in luxury retail and potential macroeconomic headwinds affecting consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Tapestry, Inc.
Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →
